Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease - authors' reply.

Festi D; Schiumerini R; Scaioli E; Colecchia A

doi:10.1111/apt.12228

Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease - authors' reply.

Festi D, Schiumerini R, Scaioli E, Colecchia A

MeSH — NLM indexing Fatty Liver / diagnosis Humans

Azioni del personale

Scarica PDF

I file sono per uso autorizzato solo nei canali dei partner BioPredictive.

Fibrotest Actitest Letter Independent Group Italy

Autori (4)

Citazione

Festi D, Schiumerini R, Scaioli E, Colecchia A. Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease - authors' reply. Aliment Pharmacol Ther. 2013;37(6):656-7. doi:10.1111/apt.12228.

Identificatori

DOI: 10.1111/apt.12228
PMID: 23406410

Test

Malattie del fegato

Lesioni epatiche

Argomenti

Regione

Carrello

Il carrello è vuoto.

Sfoglia le pubblicazioni e usa Aggiungi al carrello su qualsiasi pagina di dettaglio per creare un archivio ZIP da inviare ai clienti.

Sfoglia le pubblicazioni

Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease - authors' reply.

Altre di Festi D

Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.

Altro sullo stesso argomento

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Noninvasive Assessment of Liver Fibrosis.

Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.

Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).